Komori
Presentation materials for financial results6988NITTO DENKO CORPORATIONMaterials and Chemicals

Supplementary Materials to the Consolidated Summary of Financial Results for the Fiscal Year Ending March 2026 (IFRS)

In fiscal 2025, revenue increased 1.4% year on year, while operating profit declined 1.1% and profit for the year attributable to owners of the parent declined 2.7%. For fiscal 2026, the Company forecasts revenue of ¥1,065.0 billion, operating profit of ¥193.0 billion and profit for the year of ¥141.0 billion.

Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFiscal year ending March 20265 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,028,171 million+1.4%
Operating profit¥183,615 million-1.1%
Ordinary income¥184,976 million-0.2%
Net income¥133,498 million-2.7%
Operating profit margin17.9 %
Results for the three months of the current quarter
Fiscal 2025 Q4 (January–March)
Revenue
¥241,976 million
Operating profit
¥35,755 million
Income before taxes
¥89,808 million
Profit for the period attributable to owners of the parent
¥64,572 million
Full-year earnings forecast
Revenue
¥1,065,000 million
Operating profit
¥193,000 million
Income before taxes
¥193,000 million
Profit for the period attributable to owners of the parent
¥141,000 million
Capital expenditures
¥120,000 million
Depreciation and amortization
¥79,000 million
Research and development costs
¥50,000 million
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
¥153 per US$1
Key KPIsA metric the company considers important as a management benchmark.
  • Basic earnings per share¥197.2
  • Payout ratio30.4 %
    Year on year against the same period last year+1.8 percentage points
  • ROA9.7 %
    Year on year against the same period last year-1.0 percentage points
  • ROE12.2 %
    Year on year against the same period last year-1.3 percentage points
  • Operating margin17.9 %
    Year on year against the same period last year-0.4 percentage points
  • Equity ratio79.6 %
    Year on year against the same period last year+0.6 percentage points
Segment results
  • Industrial Tape
    Revenue¥366,607 million
    Operating profit¥51,662 million
    Revenue_yoy_pct4.2
    Operating profit_yoy_pct12.6
  • Optoronics
    Revenue¥527,812 million
    Operating profit¥149,871 million
    Revenue_yoy_pct-2.6
    Operating profit_yoy_pct-13.4
  • Human Life
    Revenue¥143,702 million
    Operating profit¥-5,041 million
    Revenue_yoy_pct8.5
  • Other
    Revenue¥11 million
    Operating profit¥-6,971 million
  • Adjustments
    Revenue¥-9,961 million
    Operating profit¥-5,905 million
Capital expenditures
¥86,841 million
Payout ratio
30.6 %
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredFiscal year ending March 2026
Net Sales¥1,028,171 million (YoY +1.4%)
Operating profit¥183,615 million (YoY -1.1%)
Ordinary income¥184,976 million (YoY -0.2%)
Net income¥133,498 million (YoY -2.7%)
Operating profit margin17.9 %
Results for the three months of the current quarterSubject Fiscal 2025 Q4 (January–March) / Revenue ¥241,976 million / Operating profit ¥35,755 million / Income before taxes ¥89,808 million / Profit for the period attributable to owners of the parent ¥64,572 million
Full-year earnings forecastRevenue ¥1,065,000 million / Operating profit ¥193,000 million / Income before taxes ¥193,000 million / Profit for the period attributable to owners of the parent ¥141,000 million / Capital expenditures ¥120,000 million / Depreciation and amortization ¥79,000 million / Research and development costs ¥50,000 million
Segment resultsSegment Industrial Tape / Revenue ¥366,607 million / Operating profit ¥51,662 million / Revenue_yoy_pct 4.2 / Operating profit_yoy_pct 12.6, Segment Optoronics / Revenue ¥527,812 million / Operating profit ¥149,871 million / Revenue_yoy_pct -2.6 / Operating profit_yoy_pct -13.4, Segment Human Life / Revenue ¥143,702 million / Operating profit ¥-5,041 million / Revenue_yoy_pct 8.5, Segment Other / Revenue ¥11 million / Operating profit ¥-6,971 million, Segment Adjustments / Revenue ¥-9,961 million / Operating profit ¥-5,905 million
Key KPIsIndicator Basic earnings per share / Value ¥197.2 / Year on year against the same period last year Not disclosed, Indicator Payout ratio / Value 30.4 % / Year on year against the same period last year +1.8 percentage points, Indicator ROA / Value 9.7 % / Year on year against the same period last year -1.0 percentage points, Indicator ROE / Value 12.2 % / Year on year against the same period last year -1.3 percentage points, Indicator Operating margin / Value 17.9 % / Year on year against the same period last year -0.4 percentage points, Indicator Equity ratio / Value 79.6 % / Year on year against the same period last year +0.6 percentage points
Assumptions Underlying the Business OutlookExchange rate ¥153 per US$1
Payout ratio30.6 %
Capital expenditures¥86,841 million
Items this document does not state (17)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This material does not explain the reasons for the increases or decreases in performance.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials to the Consolidated Summary of Financial Results for the Fiscal Year Ending March 2026 (IFRS) | NITTO DENKO CORPORATION (6988) timely disclosure | Komori